<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">HPeV3 has been identified in several countries in Asia, North America and Europe
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>,
  <xref ref-type="bibr" rid="CR7">7</xref>–
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>. It was first described in 2004 in a sample collected from a young girl in Japan in 1999
 <sup>
  <xref ref-type="bibr" rid="CR7">7</xref>
 </sup> and subsequent retrospective studies have found HPeV3 in samples from as early as 1994 in the Netherlands
 <sup>
  <xref ref-type="bibr" rid="CR13">13</xref>
 </sup>. The epidemiology of HPeV3 appears to be different to other human parechoviruses, with epidemics of infection reported in young children and neonates every 2–3 years
 <sup>
  <xref ref-type="bibr" rid="CR14">14</xref>,
  <xref ref-type="bibr" rid="CR15">15</xref>
 </sup>.
</p>
